Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/51101
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2020-01-31T07:17:19Z-
dc.date.available2020-01-31T07:17:19Z-
dc.date.issued2010-03-
dc.identifier.citationAttard, A., Cilia, M., Zammit, M. C., Wirth, F., Coleiro, B., Zarb Adami, M.,…Serracino-Inglott, A. (2010, March). Bioequivalence of doxazosin slow release tablets: a pilot study. Poster session presented at the 7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Valletta, Malta.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/51101-
dc.description.abstractA poster presentation regarding a pilot study on the bioequivalence of doxazosin slow release tablets. Introduction: Bioequivalence studies are carried out to compare the systemic exposure profile of a test drug product to that of a reference product. Doxazosin is a potent quinazoline derivative and is effective for the treatment of hypertension and benign prostatic hyperplasia. Aim: To carry out a pilot bioequivalence study to assess comparative bioavailability between test product, doxazosin mesylate 8mg slow release tablets and reference product, Cardura®XL 8mg tablets.en_GB
dc.language.isoenen_GB
dc.publisherUniversity of Malta. Department of Pharmacyen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectDrugs -- Therapeutic equivalencyen_GB
dc.subjectDoxazosin -- Analysisen_GB
dc.subjectDoxazosin -- Therapeutic useen_GB
dc.subjectHigh performance liquid chromatography -- Methodologyen_GB
dc.titleBioequivalence of doxazosin slow release tablets : a pilot studyen_GB
dc.typepresentationen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorAttard, Alison-
dc.contributor.creatorCilia, Mark-
dc.contributor.creatorZammit, Marie Clare-
dc.contributor.creatorWirth, Francesca-
dc.contributor.creatorColeiro, Bernard-
dc.contributor.creatorZarb Adami, Maurice-
dc.contributor.creatorAzzopardi, Lilian M.-
dc.contributor.creatorSerracino-Inglott, Anthony-
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Bioequivalence_of_doxazosin_slow_release_tablets_a_pilot_study_2010.pdf1.1 MBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.